Page last updated: 2024-10-17

citric acid, anhydrous and Thrombotic Microangiopathies

citric acid, anhydrous has been researched along with Thrombotic Microangiopathies in 2 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Thrombotic Microangiopathies: Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McGuckin, S1
Westwood, JP1
Webster, H1
Collier, D1
Leverett, D1
Scully, M1
Kissling, S1
Legallais, C1
Pruijm, M1
Teta, D1
Vogt, B1
Burnier, M1
Rondeau, E1
Ridel, C1

Other Studies

2 other studies available for citric acid, anhydrous and Thrombotic Microangiopathies

ArticleYear
Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience.
    Vox sanguinis, 2014, Volume: 106, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Citric Acid; Female; Humans; Hypersensitivity; M

2014
A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
    BMC nephrology, 2017, 03-01, Volume: 18, Issue:1

    Topics: Adult; Aged; Algorithms; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Anticoagulants;

2017